Search Results

You are looking at 1 - 1 of 1 items for

  • Author or Editor: Uptal D. Patel x
  • Refine by Content Type: All x
Clear All Modify Search
Ian H. de Boer, Grant Olan, and Uptal D. Patel

In 2012, the Agency for Healthcare Research and Quality (AHRQ) comprehensively summarized the available evidence evaluating the risks and benefits of screening for chronic kidney disease (CKD) in the general population. Utilizing these data, the U.S. Preventive Services Task Force (USPSTF) determined that existing evidence was insufficient to balance the benefits and harms of routine screening for CKD in asymptomatic adults. Subsequently, the USPSTF identified screening for CKD as its top priority in a report to Congress on high-priority evidence gaps for clinical preventive services. USPSTF also identified screening for CKD in African Americans as the most important evidence gap